MDMA approval for post-traumatic stress disorder could come in 2024
The Food and Drug Administration soon may approve the recreational psychedelic drug MDMA — alongside supportive therapy — to treat post-traumatic stress disorder after two late-stage studies found it effective. MDMA facilitates empathy and openness and decreases defensiveness, but it also induces neuroplasticity — the ability of neurons to rewire and strengthen connections, said Ronald… Read More